Corona vaccine COVAXIN preclinical study completed now human trial

Corona vaccine COVAXIN preclinical study completed now human trial. Corona’s vaccine covaxin may launch on August 15. The launch of this vaccine is possible by pharmaceutical company Bharat Biotech and Indian Council of Medical Research (ICMR). ICMR has released a statement on Saturday regarding the vaccine. The ICMR says the preclinical study of the vaccine has successfully completed. And now phase 1 and 2 of human trials are schedule to begin.

Corona vaccine COVAXIN preclinical study completed now human trial Corona vaccine COVAXIN preclinical study completed now human trial

“In the public health interest, it is important for us to speed up trials of an indigenous vaccine,” ICMR said. The ICMR process on vaccine fine as per globally accepted norms.

The ICMR says our aim is to complete all phases of the vaccine as soon as possible. So that population-based trials can be introduced without delay. Covaxin has recently allowed human trials.

According to a letter issued by ICMR, the enrolment for human trials will start from July 7. Then, if all the trials correct. It expected that covaxin can launch near August 15. First, India can come into the biotech vaccine market.

In the past, Hyderabad pharma company Bharat Biotech had claimed. That it had also received the green signal from DCGI for phase-I and phase-II human trials of covaxin. The company has also said that the trial will  launch in the first week of July. India has a longstanding experience in biotech vaccine making.